121 related articles for article (PubMed ID: 32894794)
21. The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis.
Orwoll ES; Scheele WH; Paul S; Adami S; Syversen U; Diez-Perez A; Kaufman JM; Clancy AD; Gaich GA
J Bone Miner Res; 2003 Jan; 18(1):9-17. PubMed ID: 12510800
[TBL] [Abstract][Full Text] [Related]
22. Characterizing patients initiating abaloparatide, teriparatide, or denosumab in a real-world setting: a US linked claims and EMR database analysis.
Imel EA; Starzyk K; Gliklich R; Weiss RJ; Wang Y; Williams SA
Osteoporos Int; 2020 Dec; 31(12):2413-2424. PubMed ID: 32696118
[TBL] [Abstract][Full Text] [Related]
23. Acting on black box warnings requires a GRADE evidence table and an implementation guide: the case of teriparatide.
Elraiyah T; Gionfriddo MR; Murad MH
J Clin Epidemiol; 2015 Jun; 68(6):698-702. PubMed ID: 25766055
[TBL] [Abstract][Full Text] [Related]
24. Bone cancer incidence by morphological subtype: a global assessment.
Valery PC; Laversanne M; Bray F
Cancer Causes Control; 2015 Aug; 26(8):1127-39. PubMed ID: 26054913
[TBL] [Abstract][Full Text] [Related]
25. Incidence Trends in the Diagnosis of Giant Cell Tumor of Bone in Sweden Since 1958.
Rockberg J; Bach BA; Amelio J; Hernandez RK; Sobocki P; Engellau J; Bauer HC; Liede A
J Bone Joint Surg Am; 2015 Nov; 97(21):1756-66. PubMed ID: 26537163
[TBL] [Abstract][Full Text] [Related]
26. Teriparatide: a review.
Quattrocchi E; Kourlas H
Clin Ther; 2004 Jun; 26(6):841-54. PubMed ID: 15262455
[TBL] [Abstract][Full Text] [Related]
27. Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma.
Lee JS; DuBois SG; Boscardin WJ; Wustrack RL; Goldsby RE
Cancer; 2014 Dec; 120(24):3987-93. PubMed ID: 25116228
[TBL] [Abstract][Full Text] [Related]
28. Regional variation and challenges in estimating the incidence of giant cell tumor of bone.
Liede A; Bach BA; Stryker S; Hernandez RK; Sobocki P; Bennett B; Wong SS
J Bone Joint Surg Am; 2014 Dec; 96(23):1999-2007. PubMed ID: 25471915
[TBL] [Abstract][Full Text] [Related]
29. Fluoride in drinking water and osteosarcoma incidence rates in the continental United States among children and adolescents.
Levy M; Leclerc BS
Cancer Epidemiol; 2012 Apr; 36(2):e83-8. PubMed ID: 22189446
[TBL] [Abstract][Full Text] [Related]
30. Age-specific fluoride exposure in drinking water and osteosarcoma (United States).
Bassin EB; Wypij D; Davis RB; Mittleman MA
Cancer Causes Control; 2006 May; 17(4):421-8. PubMed ID: 16596294
[TBL] [Abstract][Full Text] [Related]
31. Teriparatide treatment patterns in osteoporosis and subsequent fracture events: a US claims analysis.
Bonafede MM; Shi N; Bower AG; Barron RL; Grauer A; Chandler DB
Osteoporos Int; 2015 Mar; 26(3):1203-12. PubMed ID: 25567774
[TBL] [Abstract][Full Text] [Related]
32. Persistence with biologic therapies in the Medicare coverage gap.
Tamariz L; Uribe CL; Luo J; Hanna JW; Ball DE; Krohn K; Meadows ES
Am J Manag Care; 2011 Nov; 17(11):753-9. PubMed ID: 22084895
[TBL] [Abstract][Full Text] [Related]
33. Comments on Initial experience with teriparatide in the United States.
Harper KD; Krege JH; Marcus R; Mitlak BH
Curr Med Res Opin; 2006 Oct; 22(10):1927. PubMed ID: 17022851
[No Abstract] [Full Text] [Related]
34. Association of Patient Enrollment in Medicare Part D With Outcomes After Acute Myocardial Infarction.
Goyal A; de Lemos JA; Peng SA; Thomas L; Amsterdam EA; Hockenberry JM; Peterson ED; Wang TY
Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):567-75. PubMed ID: 26508667
[TBL] [Abstract][Full Text] [Related]
35. Incidence, epidemiology and treatment results of osteosarcoma in Finland - a nationwide population-based study.
Sampo M; Koivikko M; Taskinen M; Kallio P; Kivioja A; Tarkkanen M; Böhling T
Acta Oncol; 2011 Nov; 50(8):1206-14. PubMed ID: 22023116
[TBL] [Abstract][Full Text] [Related]
36. Initial experience with teriparatide in the United States.
Gold DT; Pantos BS; Masica DN; Misurski DA; Marcus R
Curr Med Res Opin; 2006 Apr; 22(4):703-8. PubMed ID: 16684431
[TBL] [Abstract][Full Text] [Related]
37. International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons.
Mirabello L; Troisi RJ; Savage SA
Int J Cancer; 2009 Jul; 125(1):229-34. PubMed ID: 19330840
[TBL] [Abstract][Full Text] [Related]
38. Present at the beginning: a personal reminiscence on the history of teriparatide.
Marcus R
Osteoporos Int; 2011 Aug; 22(8):2241-8. PubMed ID: 21452026
[TBL] [Abstract][Full Text] [Related]
39. Endogenous gonadal hormone exposure and bone sarcoma risk.
Cooley DM; Beranek BC; Schlittler DL; Glickman NW; Glickman LT; Waters DJ
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1434-40. PubMed ID: 12433723
[TBL] [Abstract][Full Text] [Related]
40. Bone sarcoma incidence in the Netherlands.
Goedhart LM; Ho VKY; Dijkstra PDS; Schreuder HWB; Schaap GR; Ploegmakers JJW; van der Geest ICM; van de Sande MAJ; Bramer JA; Suurmeijer AJH; Jutte PC
Cancer Epidemiol; 2019 Jun; 60():31-38. PubMed ID: 30903831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]